A New Milestone for Breast Cancer Care: Cryoablation is Now FDA-Cleared for Low-Risk Patients
Becoming the first-and-only medical device to be FDA approved for low-risk breast cancer, ProSense® cryoablation is poised to be a game changer to provide minimally invasive treatment for appropriately selected patients.
Cryoablation Eases Pain for Terror Victim
Cryoablation, the process of destroying tissue with ultra-low freezing temperatures, is being used around the world to treat a growing number of clinical indications. In many cases, the driving force behind a novel use of cryoablation is driven not by researchers or physicians, but by the patients themselves. In this blog, we highlight the case […]
A step forward towards cryoablation for early-stage breast cancer: Final 5-year results of the ICE3 trial
Researchers are consistently pushing back the boundaries of what is possible for the treatment of breast cancer. Results of one of the most exciting and innovative trials in breast cancer, the ICE3 Trial on cryoablation of early stage, low-risk breast cancer, were recently published in the Annals of Surgical Oncology by Dr. Richard Fine. In […]
Cancer in Kidney Transplant Patients – Occurrence Frequency & Treatment Options
Many kidney transplant patients are overcoming the immediate threat of kidney disease only to face the challenge of a cancer diagnosis. This has many implications but for those who face kidney cancer in their transplanted kidney, it’s essential to find a suitable treatment. For a kidney recipient who has only one kidney, cryoablation offers a […]
Is cryo-immunology the next frontier for cryoablation?
Cryoablation represents a frontier in minimally invasive cancer treatment, offering a novel approach to the destruction of both benign and malignant tumors. This procedure leverages extreme cold, applied directly to the tumor site, to induce cell death without the need for traditional surgical removal. The appeal of cryoablation lies in its simplicity and the reduced […]
What We Learned About Cancer in 2023
The year 2023 marked a significant era in the journey of oncology. With the blend of advancements in technology, dedicated research, and an unwavering commitment from the scientific community, we gained new insights and made remarkable progress in understanding and combating cancer. Here we share the key developments in cancer research in 2023, starting from […]
Breast Fibroadenoma Management: Treatment Without Surgery
Statistics reveal that fibroadenomas are one of the most prevalent breast conditions, affecting approximately 10% of women. Yet, available treatment options for these non-cancerous breast tumors are limited and often involve invasive surgery. Women often find themselves looking for less invasive, yet effective options to manage their fibroadenomas. This article will explore the prevalence of […]
Cryoablation for Breast Cancer – Evidence to date
Cryoablation, the use of extreme cold to destroy tumors by freezing, is emerging as an innovative treatment for breast cancer.* Breast cancer is a disease that impacts approximately one in eight women in their lifetime. Current standards of breast cancer treatment can involve surgery, radiation, chemotherapy, hormone therapy, and targeted therapy. As a minimally invasive […]
Liquid Nitrogen Cryoablation – Advancing the Frontiers of Tumor Cryoablation
The medical world is increasingly embracing cryotherapy for tumor treatment, but not all cryoablation treatments are created equal. Liquid nitrogen (LN2) cryoablation technology, the coldest of the cryogens, is taking the stage for more effective treatment and outcomes. Cryoablation has become an established method of therapy in the corridors of oncology, enabling minimally invasive treatment […]
Interventional oncology: a minimally invasive way to target cancer
The development of new and more effective cancer treatments is breaking previous limitations and providing clinicians with new and more capable tools to fight the disease. The traditional pillars of cancer treatment have been surgery, radiotherapy, and chemotherapy. Now cancer patients have the benefit of a fourth pillar, interventional oncology (IO), to diversify and personalize […]